Lymphoma, B-Cell, Marginal Zone - 24 Studies Found

Completed : Marginal Zone Lymphoma Cohort in Korea
: Lymphoma, B-Cell, Marginal Zone
: 2016-04-04
: Other: Rituximab Cohort observation study
Completed : Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
: Lymphoma, B-Cell, Marginal Zone
: 2017-03-23
: Drug: Ibrutinib 560mg administered orally once daily.
Completed : Endomicroscopy and Gastric MALT-lymphoma
: MALT-lymphoma
: 2012-01-08
:
  • Procedure: Confocal laser endomicroscopy

Completed : Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
: Marginal Zone B-cell Lymphoma
: 2015-04-05
: Drug: bendamustine plus rituximab Bendamustine 90mg/m2 IV on days 1-2 up to 6th cycle Rituximab 375mg/m2
Active, not recruiting : Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma
: MALT Lymphoma
: 2013-03-06
:
  • Drug: Chlorambucil
  • Drug: Rituximab i.v.
Completed : Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma
: Mucosa-Associated Lymphoid Tissue Lymphoma
: 2016-12-01
Not yet recruiting : A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
:
  • Relapsed Marginal Zone Lymphoma
  • Refractory MALT Lymphoma
    : 2005-09-13
    : Other: Omeprazole, Amoxicillin, Clarithromycin Omeprazole20 mg,Clarithromycin500 mg b.i.d.,Day 1-14 plus
Completed : Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
: Marginal Zone Lymphoma
: 2007-03-27
:
  • Drug: Rituximab IV Infusion of
Active, not recruiting : Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
: Non-gastric Marginal Zone Lymphoma
: 2006-09-14
: Radiation: Involved Field Radiotherapy The prescribed dose
Next >>>